UNSPSC 51183404: Repaglinide

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 668Z8C33LU. European Medicines Agency schedules Repaglinide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10280MIG. Repaglinide generally arises in the molecular formula C27H36N2O4.

UNSPSC 51183404 Repaglinide is a Commodity code covering a meglitinide-class antidiabetic agent used to manage type 2 diabetes. State and local governments procure this pharmaceutical through pharmacy benefit managers, group purchasing organizations, Medicaid programs, and direct agency purchasing for correctional facilities, public health clinics, and behavioral health systems. The drug is typically acquired as part of formulary management and chronic disease treatment protocols rather than as a standalone line item; procurement volumes and frequency depend on patient populations served and clinical protocols within each jurisdiction's healthcare delivery system.

The source provides no records of recent state or local contract opportunities solicited under this code, preventing characterization of active issuing-body types, geographic concentration, or representative current buys.